共 68 条
[1]
Geremia A(2014)Innate and adaptive immunity in inflammatory bowel disease Autoimmun Rev 13 3-10
[2]
Biancheri P(2018)Bacterial imbalance and gut pathologies: association andcontribution of E. coli in inflammatory bowel disease Crit Rev Clin Lab Sci 29 1-17
[3]
Allan P(2018)Current, experimental, and future treatments in inflammatory bowel disease: a clinical review Immunopharmacology and Immunotoxicology 40 446-460
[4]
Khan S(2017)Dysbiosis and the immune system Nat Rev Immunol 17 219-232
[5]
Imran A(2014)The microbiome in inflammatory bowel disease: current status and the future ahead Gastroenterology 146 1489-1499
[6]
Malik A(2012)The gut microbiota in IBD Nat Rev Gastroenterol Hepatol 9 599-608
[7]
Hvas Christian L.(2015)Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific Gut 64 1063-1071
[8]
Bendix Mia(2014)The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition Proc Natl Acad Sci U S A 111 2247-2252
[9]
Dige Anders(2019)Gastrointestinal Infection Increases Odds of Inflammatory Bowel Disease in a Nationwide Case–Control Study Clinical Gastroenterology and Hepatology 17 1311-1322.e7-610.e4
[10]
Dahlerup Jens F.(2018)Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course Cell Host Microbe 24 600-5024